Skip to content

Comparing the effects of dry needling of ankle plantar flexor muscles on neuromodulation, spasticity, and balance in people with MS and stroke.

Comparative Effects of Dry Needling of Gastrocnemius -Soleus muscles on Neuromodulation, Spasticity, and Balance in patients with MS (relapsing-remitting) and stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230206057343N1
Enrollment
20
Registered
2023-02-09
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Multiple Sclerosis (Remitting Relapsing). Condition 2: Stroke. Multiple sclerosis Cerebellar stroke syndrome

Interventions

Intervention group: Dry needling will be done on the internal and external head of the gastrocnemius muscle, and the soleus muscle (in the area of the motor point) by using a 0.30 x 50 mm foliform n

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Remitting and relapsing Multiple sclerosis disease Having a stroke EDSS score less than 4 in the group of MS patients Follow instructions Spasticity of plantarflexors is equal to or greater than 1 using (MMAS scale) No diabetes Absence of any history of treatment with nerve blockers, or treatment with botulinum toxin A 6 months before entering the study. No history of attacks in MS patients in the last 8 weeks Absence of limitation of passive range of motion of more than 10 percent in ankle dorsiflexion compared to the less involved leg (absence of contracture). Absence of other neurological disorder

Exclusion criteria

Exclusion criteria: Fear of dry needling Recurrent stroke during the patient evaluation and intervention program Occurrence of a new attack in a patient with MS Contraindications to the use of TMS

Design outcomes

Primary

MeasureTime frame
Neuromodulation. Timepoint: Before the intervention, After 3 sessions of intervention, and 2 weeks after for follow up. Method of measurement: With Trans-cranial magnetic stimulation parameters, Including motor evoked potential (MEP) amplitude at rest and muscle motor threshold at rest (RMT) and motor evoked potential amplitude ratio in intracortical inhibition protocol (SICI) and motor evoked potential amplitude ratio in intracortical facilitation protocol (ICF).;Spasticity. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: Modified Modified Ashworth Scale.

Secondary

MeasureTime frame
Functional Balance. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: Timed up and go test and Four Square Step test.;Active and Passive ankle dorsiflexion ROM. Timepoint: Before the intervention, after 3 sessions of intervention sessions, and two weeks after the last intervention session for follow-up. Method of measurement: The evaluation will be done using a goniometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNastaran Ghotbi

Tehran University of Medical Sciences

nghotbi@tums.ac.ir+98 21 7753 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026